Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
NCT ID: NCT03892967
Description: None
Frequency Threshold: 0
Time Frame: Adverse events were collected from baseline to end of study participation for up to 46 months (beginning from a participants' index medical oncology encounter until death or end of study) for all participants
Study: NCT03892967
Study Brief: Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Usual Care (Control) Participants were administered ePROM surveillance alone. Participants who responded to \>=2 ePROMs were included in the analytic cohort. 2214 None 0 16180 0 16180 View
EHR-facilitated Collaborative Care (Intervention) Participants were administered ePROMs during EHR-facilitated collaborative care (ECC) periods. Automated responses, matched to symptom type and intensity, appeared following a patient's report of an actionable symptom, defined as \>=4/10 on a numeric rating scale (NRS). For any actionable symptom, respondents were asked if they wanted to receive symptom-specific self-management resources. For severe symptoms, \>=7/10, respondents were asked if they wanted to work remotely with a Symptom Care Manager (SCM) to develop an individualized symptom management plan. Participants who responded to \>=2 ePROMs were included in the analytic cohort. 3192 None 0 24874 0 24874 View
Serious Events(If Any):
Other Events(If Any):